Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Pleural Effusion | Research

Incidence, aetiology and clinical features of eosinophilic pleural effusion: a retrospective study

Authors: Minfang Li, Yunxiang Zeng, Yaqing Li, Dan Jia, Sheng Chen, Jinlin Wang

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Eosinophilic pleural effusion (EPE) is a distinct entity among pleural effusions, but its diagnostic and prognostic significance is still controversial. This study aimed to evaluate the incidence and aetiological distribution of EPE in our institution and to assess the relationship between EPE and malignancy and other underlying diseases and the relevance of the percentage of eosinophils and other laboratory parameters.

Methods

A retrospective study was conducted by reviewing the medical records of 252 patients with PE from September 2017 to January 2021.

Results

EPE was found in 34 (13.49%) out of 252 patients. There were 20 (58.82%) males and 14 (41.18%) females in the EPE group. The mean percentage of eosinophils in EPE (21.7%, range (10.0–67.5%)) was significantly higher than the percentage of eosinophils in peripheral blood (5.65%, range (0–34.60%); p < 0.05). The most common cause of EPE was malignant disease (52.94%), followed by idiopathy (14.71%), parasites (8.82%), pneumonia (8.82%) and others (14.71%). Comparative analysis of patients with malignant versus nonmalignant EPE showed that patients with malignant EPE were significantly older, and had a lower white blood cell (WBC) count in the pleural fluid (1.8 vs 4.7 cells × 109/L, p < 0.05). However, the percentage of eosinophils in PE was not significantly different between malignant EPE and nonmalignant EPE (p = 0.66). There was no correlation between the percentage of eosinophils in PE and peripheral blood (r = 0.29; p = 0.09).

Conclusions

Malignant disease ranks as the leading cause of EPE. The presence of EPE should not be considered as a predictive factor of benign conditions. Pleural parasitic infestation (PPI) should be emphasized in areas with a high incidence of parasitic disease.
Literature
1.
go back to reference Harmsen W. Inaug Diss der pat. Dorpat. 1894. Harmsen W. Inaug Diss der pat. Dorpat. 1894.
2.
go back to reference Adelman M, Albelda SM, Gottlieb J, Haponik EF. Diagnostic utility of pleural fluid eosinophilia. Am J Med. 1984;77(5):915–20.CrossRef Adelman M, Albelda SM, Gottlieb J, Haponik EF. Diagnostic utility of pleural fluid eosinophilia. Am J Med. 1984;77(5):915–20.CrossRef
3.
go back to reference Kuhn M, Fitting JW, Leuenberger P. Probability of malignancy in pleural fluid eosinophilia. Chest. 1989;96(5):992–4.CrossRef Kuhn M, Fitting JW, Leuenberger P. Probability of malignancy in pleural fluid eosinophilia. Chest. 1989;96(5):992–4.CrossRef
4.
go back to reference Martinez-Garcia MA, Cases-Viedma E, Cordero-Rodriguez PJ, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J. 2000;15(1):166–9.CrossRef Martinez-Garcia MA, Cases-Viedma E, Cordero-Rodriguez PJ, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J. 2000;15(1):166–9.CrossRef
5.
go back to reference Oba Y, Abu-Salah T. The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration. 2012;83(3):198–208.CrossRef Oba Y, Abu-Salah T. The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration. 2012;83(3):198–208.CrossRef
6.
go back to reference Chu FY, Liou CB, Sun JT, et al. Eosinophilia in pleural effusions: a speculative negative predictor for malignancy. Asian Pac J Cancer Prev. 2016;17(3):1411–4.CrossRef Chu FY, Liou CB, Sun JT, et al. Eosinophilia in pleural effusions: a speculative negative predictor for malignancy. Asian Pac J Cancer Prev. 2016;17(3):1411–4.CrossRef
7.
go back to reference Krenke R, Nasilowski J, Korczynski P, et al. Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J. 2009;34(5):1111–7.CrossRef Krenke R, Nasilowski J, Korczynski P, et al. Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J. 2009;34(5):1111–7.CrossRef
8.
go back to reference Rubins JB, Rubins HB. Etiology and prognostic significance of eosinophilic pleural effusions. A prospective study. Chest. 1996;110(5):1271–4.CrossRef Rubins JB, Rubins HB. Etiology and prognostic significance of eosinophilic pleural effusions. A prospective study. Chest. 1996;110(5):1271–4.CrossRef
9.
go back to reference Ozkara SK, Turan G, Basyigit I. Clinicopathologic significance of eosinophilic pleural effusions in a population with a high prevalence of tuberculosis and cancer. Acta Cytol. 2007;51(5):773–81.CrossRef Ozkara SK, Turan G, Basyigit I. Clinicopathologic significance of eosinophilic pleural effusions in a population with a high prevalence of tuberculosis and cancer. Acta Cytol. 2007;51(5):773–81.CrossRef
10.
go back to reference Wysenbeek AJ, Lahav M, Aelion JA, Kaufmann L. Eosinophilic pleural effusion: a review of 36 cases. Respiration. 1985;48(1):73–6.CrossRef Wysenbeek AJ, Lahav M, Aelion JA, Kaufmann L. Eosinophilic pleural effusion: a review of 36 cases. Respiration. 1985;48(1):73–6.CrossRef
11.
go back to reference Li WJ, Lin ZD, Wang JL. A narrative review of malignant eosinophilic pleural effusion: incidence, etiology and prognostic significance. Ann Palliat Med. 2021;10(2):2314–22.CrossRef Li WJ, Lin ZD, Wang JL. A narrative review of malignant eosinophilic pleural effusion: incidence, etiology and prognostic significance. Ann Palliat Med. 2021;10(2):2314–22.CrossRef
12.
go back to reference Krenke R, Light RW. Drug-induced eosinophilic pleural effusion. Eur Respir Rev. 2011;20(122):300–1.CrossRef Krenke R, Light RW. Drug-induced eosinophilic pleural effusion. Eur Respir Rev. 2011;20(122):300–1.CrossRef
13.
go back to reference Al-Abcha A, Raziq F, Kherallah S, Alratroot A. Mesalamine-induced eosinophilic pleural effusion. BMJ Case Rep. 2020;13(4):e233886.CrossRef Al-Abcha A, Raziq F, Kherallah S, Alratroot A. Mesalamine-induced eosinophilic pleural effusion. BMJ Case Rep. 2020;13(4):e233886.CrossRef
14.
go back to reference Zhang G. Valproic acid-induced eosinophilic pleural effusion: a case report and brief review. Ann Clin Psychiatry. 2020;32(4):288–90.CrossRef Zhang G. Valproic acid-induced eosinophilic pleural effusion: a case report and brief review. Ann Clin Psychiatry. 2020;32(4):288–90.CrossRef
15.
go back to reference Bower G. Eosinophilic pleural effusion. A condition with multiple causes. Am Rev Respir Dis. 1967;95(5):746–51.PubMed Bower G. Eosinophilic pleural effusion. A condition with multiple causes. Am Rev Respir Dis. 1967;95(5):746–51.PubMed
16.
go back to reference Kalomenidis I, Light RW. Pathogenesis of the eosinophilic pleural effusions. Curr Opin Pulm Med. 2004;10(4):289–93.CrossRef Kalomenidis I, Light RW. Pathogenesis of the eosinophilic pleural effusions. Curr Opin Pulm Med. 2004;10(4):289–93.CrossRef
17.
go back to reference Ferreiro L, San JE, Gonzalez-Barcala FJ, et al. Eosinophilic pleural effusion: Incidence, etiology and prognostic significance. Arch Bronconeumol. 2011;47(10):504–9.CrossRef Ferreiro L, San JE, Gonzalez-Barcala FJ, et al. Eosinophilic pleural effusion: Incidence, etiology and prognostic significance. Arch Bronconeumol. 2011;47(10):504–9.CrossRef
18.
go back to reference Reechaipichitkul W, Chuesakoolvanich K. Eosinophilic pleural effusion in adults at Srinagarind Hospital. Southeast Asian J Trop Med Public Health. 2003;34(2):374–8.PubMed Reechaipichitkul W, Chuesakoolvanich K. Eosinophilic pleural effusion in adults at Srinagarind Hospital. Southeast Asian J Trop Med Public Health. 2003;34(2):374–8.PubMed
19.
go back to reference Matthai SM, Kini U. Diagnostic value of eosinophils in pleural effusion: a prospective study of 26 cases. Diagn Cytopathol. 2003;28(2):96–9.CrossRef Matthai SM, Kini U. Diagnostic value of eosinophils in pleural effusion: a prospective study of 26 cases. Diagn Cytopathol. 2003;28(2):96–9.CrossRef
20.
go back to reference Lipworth BJ, Dhillon DP. A case of eosinophilic pleural effusion complicating multiple myeloma. Scott Med J. 1988;33(3):278.CrossRef Lipworth BJ, Dhillon DP. A case of eosinophilic pleural effusion complicating multiple myeloma. Scott Med J. 1988;33(3):278.CrossRef
21.
go back to reference Chang CJ, Cheng JH, Lin MS, Dai YC, Hsiue TR. Eosinophilic pleural effusion as the first presentation of angioimmunoblastic T cell lymphoma. J Formos Med Assoc. 2007;106(2):156–60.CrossRef Chang CJ, Cheng JH, Lin MS, Dai YC, Hsiue TR. Eosinophilic pleural effusion as the first presentation of angioimmunoblastic T cell lymphoma. J Formos Med Assoc. 2007;106(2):156–60.CrossRef
22.
go back to reference Hirsch A, Ruffie P, Nebut M, Bignon J, Chretien J. Pleural effusion: laboratory tests in 300 cases. Thorax. 1979;34(1):106–12.CrossRef Hirsch A, Ruffie P, Nebut M, Bignon J, Chretien J. Pleural effusion: laboratory tests in 300 cases. Thorax. 1979;34(1):106–12.CrossRef
23.
go back to reference Lakhotia M, Mehta SR, Mathur D, Baid CS, Varma AR. Diagnostic significance of pleural fluid eosinophilia during initial thoracocentesis. Indian J Chest Dis Allied Sci. 1989;31(4):259–64.PubMed Lakhotia M, Mehta SR, Mathur D, Baid CS, Varma AR. Diagnostic significance of pleural fluid eosinophilia during initial thoracocentesis. Indian J Chest Dis Allied Sci. 1989;31(4):259–64.PubMed
24.
go back to reference Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med. 2003;9(4):254–60.CrossRef Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med. 2003;9(4):254–60.CrossRef
25.
go back to reference Luo W, Zeng Y, Shen P, He J, Wang J. Diagnostic procedure for idiopathic eosinophilic pleural effusion: a single-center experience. BMC Pulm Med. 2020;20(1):82.CrossRef Luo W, Zeng Y, Shen P, He J, Wang J. Diagnostic procedure for idiopathic eosinophilic pleural effusion: a single-center experience. BMC Pulm Med. 2020;20(1):82.CrossRef
26.
go back to reference Wang J, Luo W, Shen P, He J, Zeng Y. Retrospective study of pleural parasitic infestations: a practical diagnostic approach. BMC Infect Dis. 2019;19(1):576.CrossRef Wang J, Luo W, Shen P, He J, Zeng Y. Retrospective study of pleural parasitic infestations: a practical diagnostic approach. BMC Infect Dis. 2019;19(1):576.CrossRef
27.
go back to reference Hooper C, Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):i4-17.CrossRef Hooper C, Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):i4-17.CrossRef
28.
go back to reference Jacobson ES. A case of secondary echinococcosis diagnosed by cytologic examination of pleural fluid and needle biopsy of pleura. Acta Cytol. 1973;17(1):76–9.PubMed Jacobson ES. A case of secondary echinococcosis diagnosed by cytologic examination of pleural fluid and needle biopsy of pleura. Acta Cytol. 1973;17(1):76–9.PubMed
29.
go back to reference Fang L, Wang Y, Gao Q, Yan B, Zhou J. Recurrent eosinophilic pleuritis caused by sparganum infection: a case report and review of the literature. Medicine (Baltimore). 2020;99(22):e20226.CrossRef Fang L, Wang Y, Gao Q, Yan B, Zhou J. Recurrent eosinophilic pleuritis caused by sparganum infection: a case report and review of the literature. Medicine (Baltimore). 2020;99(22):e20226.CrossRef
30.
go back to reference Oh Y, Kim JT, Kim MK, et al. Eosinophilic pleuritis due to sparganum: a case report. Korean J Parasitol. 2014;52(5):541–3.CrossRef Oh Y, Kim JT, Kim MK, et al. Eosinophilic pleuritis due to sparganum: a case report. Korean J Parasitol. 2014;52(5):541–3.CrossRef
31.
go back to reference Yongjian Z. Clinical analysis of 50 cases of eosinophilic pleurisy. Med Rev. 1995;1(6):263–4. Yongjian Z. Clinical analysis of 50 cases of eosinophilic pleurisy. Med Rev. 1995;1(6):263–4.
32.
go back to reference Jeon K, Koh WJ, Kim H, et al. Clinical features of recently diagnosed pulmonary paragonimiasis in Korea. Chest. 2005;128(3):1423–30.CrossRef Jeon K, Koh WJ, Kim H, et al. Clinical features of recently diagnosed pulmonary paragonimiasis in Korea. Chest. 2005;128(3):1423–30.CrossRef
Metadata
Title
Incidence, aetiology and clinical features of eosinophilic pleural effusion: a retrospective study
Authors
Minfang Li
Yunxiang Zeng
Yaqing Li
Dan Jia
Sheng Chen
Jinlin Wang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01767-1

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.